Gefapixant
CAS No. 1015787-98-0
Gefapixant( AF-219 | MK-7264 )
Catalog No. M10082 CAS No. 1015787-98-0
Gefapixant (AF-219, MK-7264) is an orally active, small molecule antagonist of P2X3-containing receptor with IC50 of 30 nM (hP2X3 homotrimer) and 100-250 nM (hP2X2/3 heterotrimer).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 150 | In Stock |
|
| 50MG | 237 | In Stock |
|
| 100MG | 351 | In Stock |
|
| 200MG | 498 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGefapixant
-
NoteResearch use only, not for human use.
-
Brief DescriptionGefapixant (AF-219, MK-7264) is an orally active, small molecule antagonist of P2X3-containing receptor with IC50 of 30 nM (hP2X3 homotrimer) and 100-250 nM (hP2X2/3 heterotrimer).
-
DescriptionGefapixant (AF-219, MK-7264) is an orally active, small molecule antagonist of P2X3-containing receptor with IC50 of 30 nM (hP2X3 homotrimer) and 100-250 nM (hP2X2/3 heterotrimer); displays no inhibitory impact on any non-P2X3 subunit containing receptors (IC50 >10,000 nM at recombinant homotrimeric hP2X1, hP2X2, hP2X4, rP2X5 and hP2X7 channels); markedly and significantly reduced objective cough frequency in clinical trials.Asthma Phase 2 Clinical.
-
In VitroGefapixant displays no inhibitory impact on any non-P2X3 subunit containing receptors (IC50 values >10,000 nM at recombinant homotrimeric hP2X1, hP2X2, hP2X4, rP2X5 and hP2X7 channels).
-
In VivoGefapixant (7d bid, orally) attenuates the weight bearing laterality with complete reversal of apparent hyperalgesia at the two higher doses in a rat model of knee osteoarthritis (14d following intra-articular administration of monoiodoacetate).
-
SynonymsAF-219 | MK-7264
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorrecombinanthP2X3homotrimers|hP2X2/3heterotrimericreceptors
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number1015787-98-0
-
Formula Weight353.397
-
Molecular FormulaC14H19N5O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM ((< 1 mg/ml )
-
SMILESO=S(C1=CC(OC2=CN=C(N)N=C2N)=C(C(C)C)C=C1OC)(N)=O
-
Chemical Name5-[(2,4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Abdulqawi R, et al. Lancet. 2015 Mar 28;385(9974):1198-205.
2. Ford AP, et al. Front Cell Neurosci. 2013 Dec 19;7:267.
molnova catalog
related products
-
GSK-1482160
GSK-1482160 is a CNS-penetrant negative allosteric modulator of P2X7 receptor with oral activity.
-
Lu AF27139
Lu AF27139 is an effective and selective antagonist of P2X7 receptor (IC50s of 12 and 2.4 nM for human and rat, Kis of 22, 54, and 13 nM for mouse, human, and rat, respectively). Lu AF27139 can be used in CNS diseases studies.
-
Camlipixant
Camlipixant (BLU-5937) is an orally active purine P2X3 receptor antagonist that is potent, selective and competitive.
Cart
sales@molnova.com